Filing Details
- Accession Number:
- 0001209191-11-010192
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-16 16:44:18
- Reporting Period:
- 2010-12-31
- Filing Date:
- 2011-02-16
- Accepted Time:
- 2011-02-16 16:44:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1333170 | Nxstage Medical Inc. | NXTM | Electromedical & Electrotherapeutic Apparatus (3845) | 043454702 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1409195 | J. Michael Webb | C/O Nxstage Medical, Inc. 439 South Union Street Lawrence MA 01843 | Svp, Quality & Regulatory | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-12-31 | 5,522 | $24.88 | 29,259 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2011-02-14 | 10,000 | $20.85 | 19,259 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction reflects the withholding of shares of NxStage Medical, Inc.'s common stock to satisfy the reporting person's tax liability incurred in connection with the vesting of the second tranche of awards granted to him on March 3, 2010 (the "Award") pursuant to NxStage Medical Inc.'s 2009 Performance Share Plan. The Award was reported on a previous Form 4 filed on March 5, 2010.
- This sale was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 3, 2010.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.68 to $21.15. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
Billionaire Hedge Funds
